dual Src/KDR inhibitors (Sichuan University/Nankai University)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namedual Src/KDR inhibitors (Sichuan University/Nankai University)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVascular endothelial growth factor receptor 2 antagonistsTyrosine-protein kinase SRC inhibitors
TargetsTyrosine-protein kinase SRCVascular endothelial growth factor receptor 2
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesSichuan University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSichuan UniversityNankai University
Active IndicationsN/A
Inactive IndicationsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A